Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

16.08
+1.087.20%
Post-market: 16.07-0.0100-0.06%18:34 EDT
Volume:562.21K
Turnover:8.85M
Market Cap:215.56M
PE:-1.10
High:16.19
Open:15.10
Low:15.10
Close:15.00
52wk High:69.97
52wk Low:13.07
Shares:13.41M
Float Shares:13.40M
Volume Ratio:0.91
T/O Rate:4.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.5713
EPS(LYR):-176.5980
ROE:-64.48%
ROA:-35.71%
PB:0.88
PE(LYR):-0.09

Loading ...

BRIEF-Tonix Pharmaceuticals Announces Presentations At World Vaccine Congress Washington 2026

Reuters
·
2 hours ago

Tonix Pharmaceuticals Holding Corp. Announces Annual Shareholder Meeting

Reuters
·
Mar 21

Tonix Pharmaceuticals CEO Seth Lederman to present at BIO-Europe Spring 2026

Reuters
·
Mar 19

Tonix Pharmaceuticals replaces EisnerAmper with PwC as independent auditor

Reuters
·
Mar 18

Tonix Pharmaceuticals to present oral and two poster sessions at AACR Annual Meeting 2026

Reuters
·
Mar 18

Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-Oncology Portfolio at the American Association for Cancer Research (Aacr) Annual Meeting 2026

THOMSON REUTERS
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Jade Biosciences (JBIO) and Tonix Pharma (TNXP)

TIPRANKS
·
Mar 16

Tonix Pharmaceuticals Holding Corp. publishes investor presentation on TONMYA fibromyalgia launch and USD 208 million cash position

Reuters
·
Mar 14

Tonix Pharmaceuticals Holding Corp expected to post a loss of $2.57 a share - Earnings Preview

Reuters
·
Mar 13

Tonix Pharmaceuticals Q4 EPS $(3.98) Misses $(3.16) Estimate, Sales $5.390M Beat $2.883M Estimate

Benzinga
·
Mar 13

Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting

GlobeNewswire
·
Mar 10

Tonix Pharmaceuticals Holding Corp. Publishes Investor Presentation on TONMYA Fibromyalgia Launch and USD 208 million Cash Balance

Reuters
·
Mar 10

Tonix Pharmaceuticals publishes TNX-102 SL data in journal

TIPRANKS
·
Mar 06

Tonix Publishes Phase 1 Pharmacokinetic Studies of TONMYA in Clinical Pharmacology in Drug Development

Reuters
·
Mar 06

Erasca, Tango Therapeutics Partner on Phase 1/2 Trial for Combination Cancer Therapy

MT Newswires Live
·
Mar 05

Tonix Pharmaceuticals to Present Tonmya Poster at AAPM PainConnect Annual Meeting

Reuters
·
Mar 04

Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market to Nasdaq Global Select Market

THOMSON REUTERS
·
Mar 03

Tonix Pharmaceuticals - Received Approval From Nasdaq to Transfer Listing From Nasdaq Capital Market to the Nasdaq Global Select Market

THOMSON REUTERS
·
Mar 03

Tonix Pharmaceuticals Uplists to Nasdaq Global Select Market

Reuters
·
Mar 03

Alliance Global Partners Sticks to Their Buy Rating for Tonix Pharma (TNXP)

TIPRANKS
·
Mar 02